PXN and nephrotic syndrome: Interestingly, enhanced expression of paxillin and FA kinase have been reported in glomeruli of rat models of glomerular immune injury and in experimentally induced nephrotic syndrome [54,55], while modulation of paxillin activity and FA formation appear as a putative therapeutic target for podocytopathies [56].